11876827.txt 0 probing substrate binding   metallobetalactamase l1   stenotrophomonas maltophilia   using sitedirected mutagenesis
11876827.txt 1 abstract  background    metallobetalactamases   zniicontaining enzymes   hydrolyze   betalactam bond   penicillins cephalosporins   carbapenems     involved   bacterial antibiotic resistance       least 20 distinct organisms   produce   metallobetalactamase   these enzymes have been extensively studied using xray crystallographic computational kinetic   inhibition studies however much   still unknown about how substrates bind     catalytic mechanism   an effort   probe substrate binding   metallobetalactamase l1   stenotrophomonas maltophilia nine sitedirected mutants   l1 were prepared   characterized using metal analyses cd spectroscopy   presteady state   steady state kinetics  results  sitedirected mutations were generated   amino acids previously predicted     important   substrate binding steadystate kinetic studies using   mutant enzymes   9 different substrates demonstrated varying km   kcat values     different enzymes   substrates       direct correlation between km     effect     mutation   substrate binding could   drawn stoppedflow fluorescence studies using nitrocefin     substrate showed   only   s224d   y228a mutants exhibited weaker nitrocefin binding  conclusions    data presented herein indicate   ser224 ile164 phe158 tyr228   asn233     essential   tight binding   substrate   metallobetalactamase l1   results     work also show   km values     reliable   showing substrate binding         correlation between substrate binding     amount   reaction intermediate formed during   reaction   work represents   first experimental testing   one     computational models     metallobetalactamases
11876827.txt 2 
11876827.txt 3   overuse   antibiotics     clinic     agricultural uses has resulted     tremendous selective pressure   antibiotic resistant bacteria these bacteria become resistant     number   mechanisms such   producing enzymes   hydrolyze   inactivate   antibiotics producing efflux pumps   transport   antibiotic out     cell   modifying their cell wall components       longer bind effectively     antibiotics    most common least expensive   effective antibiotics     betalactam containing antibiotics such     penicillins cephalosporins   carbapenems  these antibiotics   mechanismbased inhibitors   transpeptidase   bacterial enzyme required     production     strong viable cell wall    response     widespread use   betalactam containing antibiotics bacteria have acquired   ability   produce betalactamases     enzymes   hydrolyze   inactivate betalactam containing antibiotics     over 300 distinct betalactamases known   these enzymes have been grouped     number   classification schemes    example bush has developed   scheme based     enzymes molecular properties   has four distinct betalactamase groups  one       alarming groups     bush group 3 enzymes     znii dependent enzymes   hydrolyze nearly   known betalactam containing antibiotics               very few known clinical inhibitors    metallobetalactamases have been further divided   bush into subgroups based   amino acid sequence identity   ba enzymes share   23 sequence identity require 2 znii ions   full activity prefer penicillins   cephalosporins   substrates     represented   metallobetalactamase ccra   bacteroides fragilis   bb enzymes share   11 sequence identity     ba enzymes require only 1 znii ion   full activity prefer carbapenems   substrates     represented     metallobetalactamase imis   aeromonas sobria     bc enzymes have only 9 conserved residues     other metallobetalactamases require 2 znii ions   activity contain   different metal binding motif than   other metallobetalactamases prefer penicillins   substrates     represented     metallobetalactamase l1   stenotrophomonas maltophilia   similar grouping scheme b1 b2   b3 based   structural properties     metallobetalactamases has recently been offered    diversity     group 3 betalactamases   best exemplified     enzymes vastly differing efficacies towards nonclinical inhibitors these differences predict   one inhibitor may   inhibit   metallobetalactamases    combat   problem     characterizing   metallobetalactamase   each     subgroups   an effort   identify   common structural   mechanistic aspect     enzymes   can   targeted     generation   an inhibitor     hoped     inhibitor when given   combination   an existing antibiotic   prove     an effective therapy against bacteria   produce   metallobetalactamase   work describes   efforts   metallobetalactamase l1   s maltophilia s maltophilia   an important pathogen   nosocomial infections   immunocompromised patients suffering   cancer cystic fibrosis drug addition aids     patients   organ transplants     dialysis    organism   inherently resistant   most antibiotics due   its low outer membrane permeability      betalactam containing antibiotics due     production     chromosomally expressed group 2e betalactamase l2     group 3c betalactamase l1  l1 has been cloned overexpressed   partially characterized   kinetic   crystallographic studies    enzyme exists     homotetramer   ca 118 kda   solution       crystalline state   enzyme tightly binds two znii ions per subunit   requires both znii ions   full catalytic activity   zn1 site has 3 histidine residues   1 bridging hydroxide   ligands     zn2 site has 2 histidines 1 aspartic acid 1 terminallybound water     bridging hydroxide   ligands spencer   coworkers used   crystal structure   modeling studies   propose   substrate binding model   identified several active site residues   were involved   substrate binding   however   model has   been tested experimentally   order   prepare tight binding inhibitors     metallobetalactamases knowledge about how substrate binds     enzymes   needed       substrateenzyme binding contacts can   maintained   any proposed inhibitor   work describes   efforts   understanding how substrates bind   metallobetalactamase l1 several sitedirected mutants   l1 were generated   characterized     results   these studies reveal   none     active site residues predicted   earlier computational studies    essential   tight substrate binding figure 1  active site residues   were mutated     study active site residues   were mutated     study figure was rendered using rasmol v 26   coordinates were obtained     protein data bank using   accession number 1 sml
11876827.txt 4 wild type l1  wildtype l1 was overexpressed   escherichia coli   purified   previously described    procedure produced an average   50 60 mg   90 pure active protein per 4 l   growth culture circular dichroism spectra were collected   wildtype samples   ensure l1 expressed using   pet26b expression system had   correct secondary structure   cd spectrum   wild type l1 showed an intense broad feature   190 nm     smaller feature   215 nm see additional file 1 cd spectra these features   consistent     sample   significant alphabeta content   compton   johnson algorithm  was used   estimate secondary structure     samples wildtype l1 was estimated   have 383 alphahelix 267 betastructure 93 antiparallel betasheet 21 parallel betasheet   153 betaturn   349 other structure these estimates     excellent agreement     crystallographically determined secondary structure   40 alphahelix   30 betastructure  metal analyses   multiple preparations   wildtype l1 demonstrated     enzyme binds 19  02 znii ions per monomer    agreement   previous results  table 2  metal content   wildtype l1   l1 mutants steady state kinetic studies were performed   multiple preparations   wild type l1     resulting kinetic data   shown   tables  when using nitrocefin   substrate   50 mm cacodylate ph 70   buffer wildtype l1 exhibited   kcat value   38  1 s1     km value   12  1 mum   inclusion   100 mum zncl2     assay buffer resulted   slightly lower values   km   higher values   kcat   inclusion   higher concentrations   znii did   further affect   steadystate kinetic constants apparently   purified recombinant enzyme does   bind its full complement   znii therefore 100 mum znii was included     subsequent kinetic studies table 3  steadystate kinetic constants   hydrolysis   cephalosporins   wildtype l1   l1 mutants table 4  steadystate kinetic constants   hydrolysis   penicillins   wildtype l1   l1 mutants table 5  steadystate kinetic constants   hydrolysis   carbapenems   wildtype l1   l1 mutants wildtype l1 exhibited kcat values   41  1 s1 19  01 s1 42  1 s1   82  5 s1     cephalosporins nitrocefin cefoxitin cefaclor   cephalothin   these same substrates   km values were 4  1 mum 11  01 mum 13  1 mum   89  15 mum respectively two penicillins were tested   substrates   penicillin g   ampicillin exhibited km values   38  12 mum   55  5 mum   kcat values   600  100 s1   520  10 s1 respectively  three carbapenems were also used   substrates   l1   biapenem imipenem   meropenem exhibited km values   32  1 mum 57  7 mum   15  4 mum   kcat values   134  4 s1 370  5 s1   157  9 s1 respectively  l1s preference   penicillins   carbapenems over cephalosporins   exemplified     kcat values     agreement   previous studies   supports l1s placement     betalactamase 3c family  rapidscanning visible spectra   25 mum wildtype l1   5 mum nitrocefin demonstrated   decrease   absorbance   390 nm an increase   485 nm     rapid increase   slower decrease   absorbance   665 nm these spectra   similar   those previously reported   wildtype l1   nitrocefin      features can   attributed   substrate decay product formation   intermediate formation   decay respectively under these conditions 22 mum intermediate was formed during   first 10 milliseconds     reaction      rate   decay     intermediate corresponds     steadystate kcat    probe further   binding   nitrocefin   wildtype l1 stoppedflow fluorescence studies were conducted   previously described     reaction   wildtype l1   nitrocefin under steadystate conditions   10c resulted     rapid decrease   fluorescence followed     ratelimiting return   fluorescence  fitting     data   described   spencer et al resulted     ks value   wildtype l1   38  5 mum  figure 2  intermediate formation   wildtype l1   l1 mutants intermediate formation   wildtype l1   l1 mutants   spectra were collected using rapid scanning vis studies     absorbance values   668 nm were converted   concentration values   described   materials   methods typical reactions were conducted   25 mum l1   mutant   5 mum nitrocefin   50 mm cacodylate ph 70 containing 100 mum zncl2   25c figure 3    stoppedflow fluorescence   wildtype l1   nitrocefin   stoppedflow fluorescence   wildtype l1   nitrocefin     typical reaction 5 10 mum wildtype l1 was mixed   various concentrations   nitrocefin     reaction was monitored   up   1 second   10c using   conditions described   materials   methods   data were fitted     double exponential using sigmaplot v 610b plot   observed rate constant versus concentration   nitrocefin solid lines were fitted     data   described   materials   methods  ser224 mutants    bbl numbering scheme proposed   reference 41 was used throughout   manuscript   sequenced subclass ba   bb metallobetalactamases except vim1 have   lysine residue   position 224      computational models   substrate binding     metallobetalactamases assume     invariant carboxylate   substrates forms an electrostatic interaction     lysine   l1   residue   position 224     serine      substratebinding model   l1 predicts     serine residue interacts     carboxylate   substrate via   water molecule    test   proposed role   ser224   l1 serine was changed   an alanine s224a aspartic acid s224d   lysine s224k   these mutants were characterized using metal analyses cd spectroscopy steadystate kinetics   presteady state kinetic studies smallscale growth cultures showed     three mutants were overexpressed   levels comparable   those   wildtype l1 largescale overexpression   purification     mutants showed     three mutants were isolatable   levels comparable   those   wildtype l1 metal analyses     s224a   s224d mutants showed   both mutants bind nearly two znii ions  like wildtype l1  however   s224k mutant binds only 10 znii per protein cd spectra     mutants were similar   those   wildtype l1 see figure   additional materials steadystate kinetic studies were conducted     three mutants   buffer containing 100 mum zncl2   ensure   both znii binding sites were saturated   these studies addition   higher concentrations   znii did   result   different values     steadystate kinetic constants   tables  when   cephalosporins were used   substrates   s224a   s224k mutants exhibited 2   4fold changes   km values    studies   cefoxitin cefaclor   cephalothin   substrate   observed kcat values     s224a   s224k mutants were 2   7fold lower however   kcat values when using nitrocefin   substrate were slightly higher  2fold     other hand   s224d mutant exhibited 3   50fold higher km values   2   20fold lower kcat values     cephalosporins tested   similar trend was observed   kinetic studies when using penicillins   substrates  generally   s224a   s224k mutants exhibited small changes   km   kcat while   s224d mutant yielded 20   40fold increased values   km   10fold decreases   kcat when using   penicillins   substrates when   carbapenems were used   substrates however   changes   km values were relatively smaller than     other substrates   2   37fold changes   kcat were observed  rapidscanning vis studies     s224x mutants were conducted   probe whether   mutations caused changes     amount   intermediate   accumulates during catalysis when 50 mum s224a was reacted   5 mum nitrocefin 17 mum intermediate formed during   first 10 milliseconds     reaction    rate   decay     intermediate was equal     steadystate kcat    spite   utilizing   number   reaction conditions   s224k   s224d mutants yielded rapidscan spectra     detectable absorbances   665 nm  indicating     intermediate     stabilized   well   these mutants     wildtype l1 stoppedflow fluorescence studies   10c     s224a s224d   s224k mutants   nitrocefin     substrate resulted   ks values   39  10 213  63   33  5 mum respectively  asn233 mutants  twothirds     sequenced metallobetalactamases have an asn   position 233      residue was predicted    shown      involved   substrate binding   activation   interacting electrostatically     substrate betalactam carbonyl however   l1 asn233   14   away     modeled position     substrate betalactam carbonyl    test   role   asn233   substrate binding   asn was changed     leucine n233l     an aspartic acid n233d   these mutants were characterized   using metal analyses cd spectroscopy steadystate kinetics   presteady state kinetic studies smallscale growth cultures showed   both mutants were overexpressed   levels comparable       wildtype l1 largescale overexpression   purification     mutants showed   both mutants were isolatable   levels comparable       wildtype l1 metal analyses     n233l   n233d mutants showed   both bind nearly two znii ions  like wildtype l1  cd spectra     mutants were similar   those   wildtype l1 steadystate kinetic studies were conducted   both mutants   buffer containing 100 mum zncl2   ensure   both znii binding sites were saturated   these studies addition   higher concentrations   znii did   result   different values     steadystate kinetic constants   tables      substrates tested   n233l   n233d mutants exhibited km values   differed less than   factor   4 than   observed   wildtype l1 tables    kcat values exhibited   these mutants     substrates also differed   less than   factor   4 except when biapenem   meropenem were used   substrates     n233d mutant   these two substrates   was   19fold   45fold decrease     kcat values when using biapenem   meropenem respectively    steadystate kinetic data generally support   prediction   asn233 does   play   large role   binding   catalysis however rapidscanning vis studies   n233l   n233d   nitrocefin demonstrate     detectable amounts   intermediate   formed during   reaction even when using   wide number   reaction conditions  stoppedflow fluorescence studies   10c     n233l   n233d mutants   nitrocefin   substrate resulted   ks values   26  9   25  8 mum respectively  tyr228 mutants    substratebinding model showed   tyr228   l1 was positionconserved   asn233     other crystallographically characterized metallobetalactamases  spencer   coworkers postulated   tyr228   part   an oxyanion hole   interacts     betalactam carbonyl   substrate   helps   stabilize   putative tetrahedral intermediate formed during substrate turnover    test   hypothesis tyr228 was changed   an alanine       phenylalanine   afford   y228a   y228f mutants respectively smallscale growth cultures showed   both mutants were overexpressed   levels comparable   those   wildtype l1 largescale overexpression   purification     y228a   y228f mutants showed   both mutants were isolatable   levels comparable   those   wildtype l1 metal analyses     mutants showed   both bind nearly two znii ions  like wildtype l1    cd spectra     mutants were similar   those   wildtype l1 steadystate kinetic studies were conducted   both mutants   buffer containing 100 mum zncl2   ensure   both znii binding sites were saturated   these studies addition   higher concentrations   znii did   result   different values     steadystate kinetic constants   tables  when cephalosporins were used   substrates   y228a   y228f mutants exhibited km values   were 6   45fold higher than those observed   wildtype l1    largest change   km was observed when cefaclor was used   substrate     smallest change was observed when nitrocefin was used   substrate   tyr228 mutants exhibited  4fold change   kcat values     cephalosporins tested  suggesting   tyr228     playing   large role   catalysis when penicillins were used   substrates   tyr228 mutants exhibited 3   13fold increased km values    2fold changes   kcat   compared     values ascertained using wildtype l1      other hand when carbapenems were used   substrates   tyr228 mutants exhibited  6fold increases   km values   compared   those values   wildtype l1  interestingly   was   2   8fold drop   kcat values     tyr228 mutants   compared   values observed   wildtype l1 when using   carbapenems   substrates rapidscanning vis spectra     reaction     y228a   y228f mutants   nitrocefin demonstrated   marked decrease     amount   intermediate formed   these mutants    reactions   50 mum mutant   5 mum nitrocefin only 075    030 mum intermediate formed     y228f   y228a mutants respectively   concentration   mutants were varied between 25   150 mum   ensure         substrate was bound however none     reactions resulted     detection   intermediate   levels observed   wildtype l1 data   shown stoppedflow fluorescence studies   10c   nitrocefin hydrolysis   y191a   y191f resulted   ks values   85  9   22  6 mum respectively  ile164   phe158 mutants    crystallographically characterized metallobetalactamases have   flexible amino acid chain   extends over   active site  previous nmr studies   ccra have shown     loop clamps down   substrate   inhibitor upon binding       speculation     distortion   substrate upon clamping down     loop may drive catalysis    crystal structure   l1 showed         large loop   extends over   active site   modeling studies have predicted   two residues ile164   phe158 make significant contacts   large hydrophobic substituents     2   6 positions   penicillins cephalosporins   carbapenems    test   prediction ile 164   phe158 were changed   large hydrophobic residues   alanines   afford   i164a   f158a mutants smallscale growth cultures demonstrated   i164a   f158a mutants were overexpressed   levels comparable       wildtype l1 data   shown largescale overexpression   purification     mutants resulted   comparable quantities   isolatable enzymes   had identical cd spectra   wildtype l1   bound slightly less znii than wildtype l1    steadystate kinetic studies were conducted   buffers containing 100 mum zncl2   ensure   both metal binding sites were saturated during   studies when using   cephalosporins nitrocefin cefoxitin   cephalothin   substrates     i164a mutant   were 2   10fold only   cefoxitin increases   km   2   4fold increases   kcat observed  however when cefaclor was used   substrate   i164a mutant exhibited   3fold decrease   km     15fold decrease   kcat      other hand   km   kcat values     i164a mutant when   penicillins   carbapenems were used   substrates were very similar   those numbers exhibited   wildtype l1 tables     when   cephalosporins were used   substrates     f158a mutant   km values observed were 7   31fold higher than those determined   wildtype l1   surprisingly   kcat values were 2   31fold higher than those exhibited   wildtype l1        i164a mutant   changes   km   kcat     penicillins   carbapenems were relatively small   compared     values obtained     cephalosporins  rapidscanning vis studies   nitrocefin hydrolysis   i164a   f158a showed   marked decrease   intermediate accumulation     i164a mutant generating  030 mum intermediate     f158a producing   detectable intermediate  stoppedflow fluorescence studies   10c resulted     ks value   31  11 mum     i164a mutant   reaction   f158a   nitrocefin was   rapid   could   determine   ks value     mutant
11876827.txt 5 betalactam containing antibiotics constitute   largest class   antibiotics   these compounds   relatively inexpensive   produce cause minor side effects     effective towards   number   bacterial strains nonetheless bacterial resistance   these antibiotics   extensive most commonly due     bacterial production   betalactamases    fact   have been over 300 distinct betalactamases reported   most   these enzymes utilize an active site serine group   nucleophilically attack   betalactam carbonyl resulting     hydrolyzed product     covalently attached     active site   combat these enzymes betalactamase inhibitors such   clavulanic acid sulbactam   tazobactam have been given   combination     betalactam containing antibiotic   treat bacterial infections  one class   betalactamases     particularly unaffected     known betalactamase inhibitors   have been shown   hydrolyze almost   known betalactam containing antibiotics including late generation carbapenems   high rates     metallobetalactamases  although       reports   metallobetalactamases isolated   major pathogens  these enzymes   produced   pathogens such   b fragilis s maltophilia   p aeruginosa     inevitable     continued   extensive use   betalactam antibiotics   result     major pathogen   produces   metallobetalactamase efforts   solve   crystal structure   one     metallobetalactamases     bound substrate molecule have failed most likely due     high activity     enzymes towards   betalactam containing antibiotics  therefore computational studies have been used extensively   study substrate binding   role     znii ions   catalysis   protonation state     active site   inhibitor binding        substrate binding models have made assumptions before   substrate was docked into   active site    some   these assumptions have been shown     invalid   certain substrates    l1 two key assumptions were made 1   bridging hydroxide functions     nucleophile during catalysis   2 zn1 coordinates   betalactam carbonyl    these assumptions   after energy minimizations ser224 was predicted   hydrogen bond     substrate carboxylate  reminiscent     role predicted   lys224   ccra  ullah et al predicted   phe158   ile 164 form hydrophobic interactions   bulky substituents     substrate suggesting     loss   these residues would only affect binding   substrates   large aromatic substituents      modeling studies   ccra  asn233 was predicted   interact     betalactam carbonyl   substrate   mutagenesis studies have supported   prediction  although asn233   sequence conserved   l1     located 14a away     modeled position     betalactam carbonyl   was predicted     play   role   substrate binding   l1     other hand   substratebinding model predicted   tyr228 was   position   offer   hydrogen bond     betalactam carbonyl   participate   an oxyanion hole   was proposed   form     substrate was hydrolyzed    using   crystal structure   modeling studies   l1 ullah et al proposed   reaction mechanism     enzyme    test   proposed mechanism     proposed roles     amino acids discussed above sitedirected mutagenesis studies were conducted   metallobetalactamase l1   reported herein   overlap extension method  was used   prepare   sitedirected mutants     variety   studies were used   probe whether   single point mutations resulted   large structural changes     mutant enzymes 1   overexpression levels   mutants were analyzed   sdspage   ensure     mutations did   result   changes     overexpression levels     enzymes     few l1 mutants     other enzyme systems     lab single point mutations often result   depressed levels   overexpression      case     mutants described here       mutants overexpressed   levels comparable   wildtype l1 data   shown 2   total amounts     mutants isolatable after chromatography were compared   wildtype l1 levels   have found   particular   metal binding mutants   l1 g periyannan rb yates   mw crowder unpublished results   glyoxalase ii    single point mutations can result   overexpressed mutants being processed into inclusion bodies   unisolatable   soluble proteins     case     mutants described here       mutants were isolated   levels comparable   wildtype l1 3 cd spectra were collected     mutants   compared     spectrum   wildtype l1 although   did   expect   large change     secondary structure   l1 upon single point mutations cd spectroscopy     most common structural technique   characterize sitedirected mutants       mutants described here exhibited cd spectra   were very similar   identical       wildtype l1 see additional file 1 cd spectra 4 metal analyses     mutants were used   probe whether point mutations caused   significant change     metal binding site     preclude metal binding   crystal structures     metallobetalactamases reveal   complex   farreaching hydrogenbonding network around   metal binding sites   disruption     network   predicted   affect metal binding          mutants described here except   s224k mutant each mutant binds wildtype   nearwildtype levels   znii after purification   s224k mutant exhibited   50 reduction   metal binding      postulate     due   electrostatic repulsions between   newly introduced lys   zn2   spite     mutants binding significant amounts   znii   included 100 mum zncl2         kinetic buffers   ensure saturation     metal binding sites     facilitate direct comparison     kinetic data 5   mutants were stable   multiple freezethaw cycles     prolonged storage  3 weeks   4c retaining  95   their activity   these five lines   evidence   were confident   none     point mutations resulted   large structural changes   l1     any kinetic differences could   attributed     changed amino acid     first approximation   substrate binding   examined   steadystate kinetics   4 cephalosporins 2 penicillins   3 carbapenems tables    compared   km values     mutants   those   wildtype l1   substrates tested were chosen because   exhibited low km values   previous kinetic studies      believed     could saturate   enzymes   substrate even     was large change   binding     point mutations   tyr228 mutants exhibited increased km values   8     9 substrates tested     smallest changes   km observed when   carbapenems were used     substrate   result supports   proposed role   tyr228   substrate binding   contrast   results     ser224 mutants suggest     residue     important   substrate binding since   s224a   s224k mutants did   exhibit any significant increases     factor    10   km   any     substrates tested only when ser224 was replaced   an asp residue was   significant increases     observed km value   6     9 substrates tested     largest changes were exhibited when   penicillins were used   substrates   result supports   observation   differential binding modes   substrates     betalactamases depending     structure     substrate    only remaining mutants   exhibited significant changes     km values were   i164a   f158a mutants   i164a mutant exhibited increased km values only when using cefoxitin     substrate suggesting an interaction     isoleucine group     methoxy group   cefoxitin   f158a mutant exhibited higher km values when using   cephalosporins   substrates suggesting an interaction     cephalosporins substituents     phenylalanine     loop   extends over   active site none     other mutants exhibited vastly different values   km   any     substrates tested an examination     kcat values     mutants revealed some surprising results   s224d mutants displayed decreased kcat values   7     9 substrates tested since similar results were   observed     s224k   s224a mutants       propose   catalytic role   ser224 instead   predict     insertion   an aspartic acid into   active site   position 224 results     change     hydrogen bonding network   l1   hydrogen bonding network   extensive     metallobetalactamases   have been characterized crystallographically    n233d mutant also exhibited greatly reduced kcat values   biapenem   meropenem       imipenem   any     other substrates tested   mutation   also predicted   affect   hydrogen bonding network around   active site   apparently interactions     enzyme     4 substituent     carbapenems has an effect   catalysis   surprisingly     increases   kcat     f158a mutants     uncertain why   mutation   residues     loop   extends over   active site would affect kcat since substrate   product binding have been predicted     very fast     reaction   nitrocefin   l1 however     note     kcatkm values   wildtype l1   f158a differ     factor less than 2   inability   propose   consistent binding model also supports   recent proposal   different substrates   l1   hydrolyzed   different mechanisms   further suggests   using steadystate kinetic constants may       valid way   probe substrate binding   l1   addition   minimal kinetic mechanism   nitrocefin hydrolysis   l1 has been reported     mechanism predicts   km does   accurately reflect substrate binding   using   mechanism  km   equal   k1  k2k3k4  k1k3k4  k2k4  k2k3   probe   directly   reaction stoppedflow absorbance studies were conducted     substrate decay rates 390 nm were studied     function   nitrocefin concentration while nitrocefin     nontypical substrate     result     dinitrosubstituted styryl substituent        substrate about     most   known about its hydrolysis mechanism therefore kinetic studies   nitrocefin   substrate allowed   us   evaluate   effect   point mutations     reaction mechanism   l1   was   clear dependence   substrate decay rates   nitrocefin concentration data   shown   did note though     amount   intermediate formed during   reactions varied considerably depending upon   mutant   l1 was used     study       mutants exhibited decreases   intermediate formation     s224d s224k f158a n233d   n233l mutants yielded rapidscanning data consistent     detectable intermediate these same mutants exhibited vastly differing km values clearly       correlation   km     presence     reaction intermediate apparently   ability   observe   intermediate     governed entirely     choice   substrate      also depends   precise arrangement   active site residues     also possible     sitedirected mutants could   utilizing   different mechanism   hydrolyze nitrocefin  recently spencer   coworkers reported   stoppedflow fluorescence studies can   used   monitor   reaction   l1   nitrocefin     an initial binding step can   directly monitored    increasing   concentration   nitrocefin   rate     initial binding step increased     maximum   fitting   these data yielded   binding constant called ks herein   nitrocefin each     l1 mutants were studied using   stoppedflow fluorescence studies     resulting data were fitted   reported   spencer et al        mutants exhibited ks values identical within error   wildtype l1 except   s224d     y228a mutants   placement     negative charge   position 224 drastically affects nitrocefin binding   results     6fold decrease   binding affinity      lesser degree   aromatic portion   tyr228 must have an effect     binding site     ks value   nitrocefin binding     mutant   decreased     factor   2 however   hydroxyl group probably does   form   hydrogen bond     substrate   proposed   using nitrocefin   substrate   km values alone   completely different conclusion   reached regarding important substrate binding residues   results presented here suggests   none     residues     study   essential   tight nitrocefin binding possibly because other parts     active site accommodate   loss   certain binding contacts table 6  km   ks values   wildtype l1   mutants   nitrocefin   substrate spencer et al also reported stoppedflow fluorescence studies when using cefaclor   meropenem   substrates   ks values   these substrates were reported     710  180   272  112 mum respectively  however     hands   rates   substrate hydrolysis were   fast when using wildtype l1     could   use substrate concentrations high enough   saturate   enzyme similarly   could   determine ks values   penicillin g   ampicillin because   observed rates   hydrolysis   low substrate concentrations were too fast   observe data even   10c
11876827.txt 6   results presented herein indicate   none     active site residues identified   computational studies   essential   tight substrate binding these data also indicate     use   km values   describe substrate binding   l1   unreliable           correlation between intermediate accumulation   substrate binding affinity these results demonstrate   new computational studies     needed   probe substrate binding   l1   these studies   currently underway   results presented herein can   used   guide these new computational studies     lead     design   potential inhibitors   hopefully   way   combat penicillin resistance   bacteria
11876827.txt 7 materials  e coli strains dh5alpha   bl21de3 plyss were obtained   gibco brl   novagen respectively plasmids pet26b   puc19 were purchased   novagen primers   sequencing   mutagenesis studies were purchased   integrated dna technologies deoxynucleotide triphosphates dntps mgso4 thermopol buffer deep vent dna polymerase   restrictions enzymes were purchased   promega   new england biolabs polymerase chain reaction was conducted using   thermolyne amplitron ii unit dna was purified using   qiagen qiaquick gel extraction kit   plasmid purification kit   qiagentip 100 midi columns wizard plus minipreps were acquired   promega luriabertani lb media was made following published procedures  isopropylbetathiogalactoside iptg biotech grade was procured   anatrace phenylmethylsulfonylfluoride pmsf was purchased   sigma protein solutions were concentrated   an amicon ultrafiltration cell equipped   ym10 diaflo membranes   amicon inc dialysis tubing was prepared using spectrapor regenerated cellulose molecular porous membranes     molecular weight cutoff   6 8000 gmol qsepharose fast flow was purchased   amersham pharmacia biotech nitrocefin was purchased   becton dickinson   solutions   nitrocefin were filtered through   fisherbrand 045 micron syringe filter cefaclor cefoxitin   cephalothin were purchased   sigma penicillin g   ampicillin were purchased   fisher imipenem meropenem   biapenem were generously supplied   merck zeneca pharmaceuticals   lederle japan respectively   buffers   media were prepared using barnstead nanopure ultrapure water  generation   sitedirected mutants   l1    overexpression plasmid   l1 pub5832 was digested   ndei   hindiii     resulting ca 900 bp piece was gel purified   ligated using t4 ligase into puc19   was also digested   ndei   hindiii   yield   cloning plasmid pl1puc19 mutations were introduced into   l1 gene   using   overlap extension method   ho et al   described previously    oligonucleotides used     preparation     mutants   shown   table    ca 900 bp pcr products were digested   ndei   hindiii   ligated into puc19   dna sequences were analyzed     biosynthesis   sequencing facility     department   biological chemistry   johns hopkins university after confirmation     sequence   mutated pl1puc19 plasmid was digested   ndei   hindiii     900 bp mutated l1 gene was gel purified   ligated into pet26b   create   mutant overexpression plasmids   test   overexpression     mutant enzymes e coli bl21de3plyss cells were transformed     mutated overexpression plasmids   small scale growth cultures were used  largescale 4 l preparations     l1 mutants were performed   described previously  protein purity was ascertained   sdspage table 1  oligonucleotides used   preparation   l1 mutants  metal content    concentrations   l1     mutants were determined   measuring   proteins absorbance   280 nm   using   published extinction coefficient   epsilon280 nm  54804 m1cm1     using   method   pace  before metal analyses   protein samples were dialyzed versus 3 x 1 l   metalfree 50 mm hepes ph 75 over 96 hours   4c   varian inductively coupled plasma spectrometer   atomic emission spectroscopy detection icpaes was used   determine metal content   multiple preparations   wild type l1   l1 mutants calibration curves were based   three standards   had correlation coefficient limits     least 09950   final dialysis buffer was used     blank     znii content     final dialysis buffers was shown      05 mum detection limit   icp   separate icp measurements   emission line   213856 nm     most intense   zinc   was used   determine   zn content     samples   errors   metal content data reflect   standard deviation sigman1   multiple enzyme preparations  steadystate kinetic studies  steadystate kinetic assays were conducted   25c   50 mm cacodylate buffer ph 70 containing 100 mum zncl2     hp 5480a diode array uvvis spectrophotometer   25c   changes   molar absorptivities deltaepsilon used   quantitate products were   m1cm1 nitrocefin deltaepsilon485  17420 cephalothin deltaepsilon265 8790 cefoxitin deltaepsilon265 7000 cefaclor deltaepsilon280 6410 imipenem deltaepsilon300 9000 meropenem deltaepsilon293 7600 biapenem deltaepsilon293 8630 ampicillin deltaepsilon235 809   penicillin g deltaepsilon235  936 when possible substrate concentrations were varied between 01   10 times   km value   kinetic studies using substrates   low km values cefoxitin nitrocefin   cephalothin     small deltaepsilon values penicillin   ampicillin   typically used substrate concentrations varied between  km   10 x km   used   much     deltaa versus time data   was linear   possible   determine   velocity steadystate kinetics constants km   kcat were determined   fitting initial velocity versus substrate concentration data directly     michaelis equation using curvefit    reported errors reflect fitting uncertainties   steadystate kinetic studies were performed   triplicate   recombinant l1     least three different enzyme preparations  circular dichroism  circular dichroism samples were prepared   dialyzing   purified enzyme samples versus 3 x 2 l   5 mm phosphate buffer ph 70 over six hours   samples were diluted   final dialysis buffer   75 mugml   jasco j810 cd spectropolarimeter operating   25c was used   collect cd spectra  stopped   flowrapidscanning uvvisible spectrophotometry  rapidscanning vis spectra   nitrocefin hydrolysis   l1     l1 mutants were collected     applied photophysics sx18mv stoppedflow spectrophotometer equipped   an applied photophysics pdl photodiode array detector     1 cm pathlength optical cell   typical experiment consisted   25 mum enzyme   5 mum nitrocefin   50 mm cacodylate buffer ph 70 containing 100 mum zncl2   reaction temperature was thermostated   25c     spectra were collected between 300   725 nm data     least three experiments were collected   averaged absorbance data were converted   concentration data   described previously   mcmannus   crowder  stoppedflow fluorescence studies   nitrocefin hydrolysis   l1 were performed   an applied photophysics sx18mv spectrophotometer using an excitation wavelength   295 nm     wg320 nm cutoff filter     photomultiplier these experiments were conducted   10c using   same buffer     rapidscanning vis studies fluorescence data were fitted   kobs  kf s  ks  s  kr   described previously      kobs  kf s  kr   using curvefit v 10
11876827.txt 8 aes atomic emission spectroscopy bp base pairs cd circular dichroism epsilon extinction coefficient icp inductively coupled plasma kcat turnover number kda kilodaltons km michaelis constant ks substrate binding constant lb luriabertani media
11876827.txt 9 
